Ishihara Sangyo Kaisha (4028) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Nov, 2025Executive summary
Net sales increased by 4.9% year-over-year to ¥145,196 million for the fiscal year ended March 31, 2025.
Operating profit declined 8.8% year-over-year to ¥10,482 million, while ordinary profit fell 23.3% to ¥11,392 million.
Profit attributable to owners of parent rose 5.3% year-over-year to ¥8,410 million.
Comprehensive income grew 6.9% year-over-year to ¥10,896 million.
Financial highlights
Gross profit increased to ¥39,531 million from ¥37,101 million year-over-year.
Basic earnings per share rose to ¥219.98 from ¥209.27 year-over-year.
Return on equity improved to 7.6% from 7.2% year-over-year.
Equity-to-asset ratio increased to 50.8% from 47.3% year-over-year.
Cash and cash equivalents at period end rose to ¥24,948 million from ¥19,982 million.
Outlook and guidance
Fiscal year ending March 31, 2026 forecast: net sales of ¥147,000 million (+1.2%), operating profit of ¥12,700 million (+21.2%), and profit attributable to owners of parent of ¥9,200 million (+9.4%).
Full-year profit per share forecasted at ¥240.46.
Dividend forecast for FY2026 is ¥100 per share (¥30 interim, ¥70 year-end).
Latest events from Ishihara Sangyo Kaisha
- Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Net sales grew 10.4% year-over-year, but net income fell sharply by 80.6%.4028
Q2 202520 Nov 2025 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 202520 Nov 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 202520 Nov 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 202620 Nov 2025 - Operating profit and net income surged, with robust outlook and higher full-year forecasts.4028
Q2 202620 Nov 2025